Section Arrow
PODD.NASDAQ
- Insulet Corp
Quotes are at least 15-min delayed:2025/10/23 16:14 EDT
After Hours
Last
 323.46
0 (0.00%)
Bid
323.45
Ask
323.7
High 323.46 
Low 321 
Volume 11779 
Regular Hours
Last
 323.46
-5.76 (-1.75%)
Day High 
330.81 
Prev. Close
329.22 
1-M High
335.58 
Volume 
411.24K 
Bid
323.45
Ask
323.7
Day Low
323.17 
Open
327.9 
1-M Low
288.02 
Market Cap 
23.17B 
Currency USD 
P/E 100.37 
%Yield -- 
10-SMA 320.01 
20-SMA 316.45 
50-SMA 326.83 
52-W High 353.5 
52-W Low 227.03 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.28/5.64
Enterprise Value
24.47B
Balance Sheet
Book Value Per Share
20.77
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
2.07B
Operating Revenue Per Share
22.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
After Hours 73.7 -0.19 -0.26%
QSIQuantum-Si2.2--0.000%-- 
After Hours 2.2 0 0.00%
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
After Hours 104.32 +1.93 +1.88%
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
After Hours 1.95 0 0.00%
MDTMedtronic plc94.21-1.69-1.76%26.49PE
After Hours 94.21 0 0.00%
Quotes are at least 15-min delayed:2025/10/23 16:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.